Sees FY25 adjusted operating earnings $105M-$130M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SUPN:
- Supernus Pharmaceuticals Updates Executive Compensation Packages
- SUPN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cantor downgrades Supernus on ‘disappointing’ depression study
- Supernus downgraded to Neutral from Overweight at Cantor Fitzgerald
- Closing Bell Movers: Shift4 down 10%, Penumbra up 8% after results